000009081 001__ 9081
000009081 005__ 20231229122545.0
000009081 0247_ $$2DOI$$a10.6083/m900nv12g
000009081 037__ $$aETD
000009081 245__ $$aGet the message! HPV vaccination recommendations
000009081 260__ $$bOregon Health and Science University
000009081 269__ $$a2021
000009081 336__ $$aFinal project
000009081 502__ $$bD.N.P.
000009081 520__ $$aEach year in the USA, 35,900 cancers are caused by the human papillomavirus 
(HPV). These cancers are preventable with the successful completion of the 2-dose HPV vaccination series at 11-12 years of age. There is an association with a strong and consistent provider recommendation and an increase in HPV vaccination rates.

A brief education on high-quality HPV vaccine recommendation improves quality of clinical staff?s recommendations while increasing refusals. Future quality improvement project may consider interventions other than education.
000009081 650__ $$aPapillomavirus Vaccines$$037654
000009081 650__ $$aPediatrics$$023687
000009081 650__ $$aQuality Improvement$$039456
000009081 650__ $$aChild$$016462
000009081 691__ $$aSchool of Nursing$$041370
000009081 7001_ $$aDavis, Kelley R.$$uOregon Health and Science University$$041354
000009081 8564_ $$9f34498be-d057-43da-b27a-910e40623a1e$$s676740$$uhttps://digitalcollections.ohsu.edu/record/9081/files/Davis.Kelley.2021.pdf
000009081 905__ $$a/rest/prod/m9/00/nv/12/m900nv12g
000009081 909CO $$ooai:digitalcollections.ohsu.edu:9081$$pstudent-work
000009081 980__ $$aTheses and Dissertations